JASON THOMAS: Open Payments
NPI 1578276234 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 48 payments from 20 companies in 2025. Trend: 2023 $970 · 2024 $1,261 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $214 |
| Merck Sharp & Dohme LLC | 7 | $214 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 5 | $74 |
| Novo Nordisk Inc | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Edwards Lifesciences Corporation | 1 | $40 |
| BridgeBio Pharma, Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Amgen Inc. | 2 | $32 |
Products named: VERQUVO, LEQVIO, JARDIANCE, BRILINTA, Wegovy, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, Attruby, OPSUMIT.
Industry payments across MI — which companies pay providers there.
